Breathing Practice for Brain and Mental Health in Cancer and Neurodegenerative Diseases

NCT06788886 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 147

Last updated 2025-12-30

No results posted yet for this study

Summary

This clinical trial studies the effect of respiratory training for enhancing brain and mental health among patients with multiple sclerosis (MS) and cancer (along with their caregivers). The relationship between respiration, cardiovascular effects in the brain, mental health, and neurophysiological mechanisms are significant for patient populations facing complex health challenges, such as those with cancer and neurodegenerative disease, and their caregivers. By measuring oxygen delivery to brain tissues and cerebrospinal fluid flow, this trial may help researchers investigate the potential benefits of respiratory training for patients with MS and cancer and their caregivers.

Conditions

  • Malignant Brain Neoplasm
  • Malignant Solid Neoplasm
  • Multiple Sclerosis
  • Neuroendocrine Tumor
  • Prostate Carcinoma

Interventions

PROCEDURE

Biospecimen Collection

Undergo blood sample collection

OTHER

Exercise Intervention

Participate in walking routines

PROCEDURE

Magnetic Resonance Imaging

Undergo MRI

OTHER

Questionnaire Administration

Ancillary studies

PROCEDURE

Respiratory Therapy

Participate in breathing sessions

Sponsors & Collaborators

Principal Investigators

  • Paul H. Min, PhD · Mayo Clinic in Rochester

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-05
Primary Completion
2027-01-18
Completion
2027-01-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06788886 on ClinicalTrials.gov